Close Menu
Daily Guardian
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
What's On

Madonna Debuts New Music in Surprise Appearance at The Abbey with MISTR

April 29, 2026

BambooHR Announces HR Virtual Summit 2026

April 29, 2026

New poll puts leaderless Ontario Liberals ahead of Ford’s Progressive Conservatives

April 29, 2026

Elegance Moves the World — LEPAS Joins Global Partners to Accelerate into the Year of Delivery

April 29, 2026

With Canada approving 1st generic semaglutide, how will costs compare?

April 29, 2026
Facebook X (Twitter) Instagram
Finance Pro
Facebook X (Twitter) Instagram
Daily Guardian
Subscribe
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
Daily Guardian
Home » Farm Animal Drugs Research Report 2026: $28.88 Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F
Press Release

Farm Animal Drugs Research Report 2026: $28.88 Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F

By News RoomApril 29, 20263 Mins Read
Farm Animal Drugs Research Report 2026: .88 Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F
Share
Facebook Twitter LinkedIn Pinterest Email

Dublin, April 29, 2026 (GLOBE NEWSWIRE) — The “Farm Animal Drugs Market Report 2026” has been added to ResearchAndMarkets.com’s offering.

The farm animal drugs market, having shown substantial growth in recent years, is expected to continue its upward trajectory. The market size, projected to rise from $20.66 billion in 2025 to $21.96 billion in 2026 at a CAGR of 6.3%, reflects significant market dynamism. This growth stems from factors such as a burgeoning global livestock population, increased prevalence of infectious animal diseases, and rising demand for animal-derived food products. The expansion of commercial farming and the availability of established veterinary drug classes also contribute significantly.

Looking towards 2030, the market is anticipated to hit $28.88 billion, growing at a CAGR of 7.1%. Key drivers include an increased focus on antimicrobial stewardship and heightened demand for high-quality animal protein. Enhanced veterinary healthcare infrastructure, stringent food safety, and animal welfare regulations further boost growth. Prominent trends in this period involve preventive veterinary medications, combination drug therapies, and a focus on food safety and residue compliance.

The surge in global meat consumption plays a pivotal role in propelling the market forward. As global populations grow and urbanization increases, demands for protein-rich diets skyrocket, consequently elevating the need for veterinary drugs that support livestock health, productivity, and meat quality. For instance, UK meat production saw an increase from 4.05 million tonnes in 2023 to 4.16 million tonnes in 2024, according to Defra.

Leading companies are innovating with solutions like moxidectin injectable treatments for parasite control, which enhance livestock productivity. In March 2023, Norbrook Laboratories Ltd. launched Tauramox, a generic moxidectin solution, after receiving FDA approval. MSD Animal Health’s acquisition of Elanco Animal Health’s aqua business in July 2024 also exemplifies strategic steps undertaken by major players to enhance their market presence.

Key players in this market include Eli Lilly and Company, Boehringer Ingelheim GmbH, Zoetis Inc., and Elanco Animal Health Incorporated, among others. Notably, the Asia-Pacific region held the largest market share in 2025, with significant activity in countries like China, India, and Japan.

Tariffs have impacted the market by inflating costs for imported active ingredients and finished products, leading to price variations. Nevertheless, these challenges have encouraged domestic manufacturing and API localization, enhancing market stability.

The farm animal drugs market research offers insights into market size, regional shares, and competitive landscapes, facilitating informed business decisions. Farm animal drugs are crucial for disease management in livestock, supporting sustainable practices and food safety standards. Primary drug categories include anti-infectives, parasiticides, and anti-inflammatory agents, utilized through various distribution channels and administration routes.

Key Attributes:

Report Attribute Details
No. of Pages 250
Forecast Period 2026 – 2030
Estimated Market Value (USD) in 2026 $21.96 Billion
Forecasted Market Value (USD) by 2030 $28.88 Billion
Compound Annual Growth Rate 7.1%
Regions Covered Global

Companies Featured

  • Eli Lilly and Company
  • Boehringer Ingelheim GmbH
  • Zoetis Inc.
  • Elanco Animal Health Incorporated
  • Hester Biosciences Limited
  • Ceva Sante Animale SA
  • Virbac SA
  • Huvepharma Inc
  • Phibro Animal Health Corporation
  • Dechra Pharmaceuticals plc
  • Laboratorios Hipra S.A.
  • Norbrook Laboratories Ltd.
  • Neogen Corporation
  • Ouro Fino Saude Animal Participacoes SA
  • Eco Animal Health Ltd
  • Biogenesis Bago SA
  • Laboratorios Calier S.A.
  • Laboratorios Syva S.A.
  • Jurox Pty Ltd
  • Kepro B.V.
  • Kyoritsu Seiyaku Corp.
  • Merck Animal Health
  • Vetoquinol SA
  • Nippon Zenyaku Kogyo Co. Ltd.
  • SeQuent Scientific Limited
  • Agrovet Market Animal Health
  • Orion Pharma Animal Health
  • Zydus Animal Health and Investments Limited

For more information about this report visit https://www.researchandmarkets.com/r/e8rb8m

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.


            
Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Keep Reading

Madonna Debuts New Music in Surprise Appearance at The Abbey with MISTR

BambooHR Announces HR Virtual Summit 2026

Elegance Moves the World — LEPAS Joins Global Partners to Accelerate into the Year of Delivery

Skyline Exhibits Wins Platinum and Gold Honors at the 2026 MUSE Creative Awards

Choctaw Casino & Resort Durant’s “3 Months. 3 Millionaires.” Returns With $6.3 Million Giveaway This Summer

Industrial Liquefied Natural Gas (LNG) Vaporizer Industry Report 2026: $1.88 Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F

Small Molecule Innovator CDMO Research Report 2026: $93.12 Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F

Nitun Ahir MD Scholarship Announces National Call for Future Physician-Leaders in Healthcare Innovation

Oatey Co. Expands Designline™ Collection with New Trellis Decorative Shower Drain Cover

Editors Picks

BambooHR Announces HR Virtual Summit 2026

April 29, 2026

New poll puts leaderless Ontario Liberals ahead of Ford’s Progressive Conservatives

April 29, 2026

Elegance Moves the World — LEPAS Joins Global Partners to Accelerate into the Year of Delivery

April 29, 2026

With Canada approving 1st generic semaglutide, how will costs compare?

April 29, 2026

Latest News

Blake Lively’s lawyers claim she lost millions in earnings ahead of trial

April 29, 2026

Skyline Exhibits Wins Platinum and Gold Honors at the 2026 MUSE Creative Awards

April 29, 2026

Choctaw Casino & Resort Durant’s “3 Months. 3 Millionaires.” Returns With $6.3 Million Giveaway This Summer

April 29, 2026
Facebook X (Twitter) Pinterest TikTok Instagram
© 2026 Daily Guardian Canada. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.

Go to mobile version